MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disease with progressive cognitive impairment, characterized by loss of neurons, plaques of insoluble amyloid-β(Aβ) and neurofibrillary tangles (NFTs) of phosphorylated microtubule-associated protein tau (P-tau) [1].